<DOC>
	<DOCNO>NCT01691651</DOCNO>
	<brief_summary>The purpose study associate use botulinum toxin type A patient keratoconus demonstrate tension eyelid important role disease progression .</brief_summary>
	<brief_title>Botulinum Toxin A Treatment Keratoconus</brief_title>
	<detailed_description>Subcutaneous injection botulinum toxin type A perform two point nasal temporal extent orbicularis muscle group patient keratoconus ( Botulinum toxin A group ) .The idea evaluate change palpebral fissure patient group botulinum toxin A period 18 months.The measurement palpebral fissure perform Image J ( version 1.34s ) program , develop National Institutes Health ( USA ) .The unit measure millimetre.The patient botulinum toxin A group compare control group , without intervention .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>patient document keratoconus bestcorrected visual acuity measurable refraction test age 1040 year good health understand procedure limitation one functional eye previous ocular surgery concurrent corneal infection ocular disease modify visual acuity know allergy botulinum toxin pregnancy poor collaboration perform examination procedure</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Keratoconus</keyword>
	<keyword>Tetanus toxin</keyword>
</DOC>